| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2022-08-10 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Umecrine Cognition recruits Anders Karlsson as the new CEO | Pressreleaser | Visa Stäng |
|
Pressreleaser |
Karolinska Development’s portfolio company Umecrine Cognition recruits Anders Karlsson as the new CEO
STOCKHOLM, SWEDEN – August 10, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the Board of Directors of the portfolio company Umecrine Cognition has recruited Anders Karlsson as the new CEO. He succeeds Magnus Doverskog, who moves on to a position as Chief Scientific Officer in the company. The recruitment aims to strengthen and broaden the management team with additional competence in business development and commercialization for the next phase in the company’s development. Anders Karlsson will take over as CEO on 1st of September, 2022. Anders Karlsson, b. 1964, is currently CEO of the biotech company Idogen (Nasdaq First North Growth Market). He has extensive experience in leading operational roles and board work within the Swedish and international life science industry. After being CEO of Novartis’ Norwegian operations, where he among other things was responsible for the commercialization of CNS drugs, he has held the role of CEO at the medical technology companies Absorber, Olerup International, Olerup SSP, and Allenex (Nasdaq Small Cap). He has also been responsible for the global operations, outside North America, in the US-listed diagnostic company CareDx Inc. Anders Karlsson has an MBA from Henley Business School, the University of Reading in the UK, as well as management education from the London Business School and Harvard. ”We are very happy to have been able to attract Anders Karlsson to the role of CEO in our portfolio company Umecrine Cognition. The recruitment will bring additional resources and competence to the management, which makes it possible for Magnus Doverskog, after ten successful years as CEO, to now focus entirely on the company’s research and development activities,” says Viktor Drvota, CEO of Karolinska Development and Chairman of the Board of Umecrine Cognition. Umecrine Cognition’s drug candidate golexanolone is being developed in the indications of primary biliary cholangitis (PBC) and hepatic encephalopathy (HE; liver coma). Golexanolone belongs to a new class of drugs that modulate the activity of the GABAA receptor in order to counteract cognitive impairment associated with liver disease and associated inflammation of the brain. The company has recently applied for approval to start a Phase 2 clinical trial of golexanolone in patients with primary biliary cholangitis. Karolinska Development’s ownership in Umecrine Cognition amounts to 73 percent. For further information, please contact : Viktor Drvota, CEO, Karolinska Development AB Johan Dighed, General Counsel and Deputy CEO, Karolinska Development AB TO THE EDITORS About Karolinska Development AB Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success. Karolinska Development has a portfolio of ten companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases. The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network. For more information, please visit www.karolinskadevelopment.com . Attachment
|
||||
| 2022-08-10 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition rekryterar Anders Karlsson som ny vd | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-07-22 | Karolinska Development AB (publ) | Karolinska Developments portfolio company Promimic and Danco Medical form a joint venture for the US-market | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-07-22 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Promimic bildar joint venture med Danco Medical i USA | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-07-04 | Karolinska Development AB (publ) | Karolinska Development expands its portfolio following an investment in PharmNovo | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-07-04 | Karolinska Development AB (publ) | Karolinska Development utökar portföljen efter genomförd investering i PharmNovo | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-06-27 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Svenska Vaccinfabriken presenterar vetenskapliga framsteg vid internationell konferens | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-06-27 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Svenska Vaccinfabriken presents scientific advancements at international conference | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-06-23 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Promimic presents preclinical results showing decreased bacterial adhesion to implants | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-06-23 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Promimic presenterar prekliniska resultat som visar minskad bakterietillväxt på implantat | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-06-03 | Karolinska Development AB (publ) | Karolinska Development invests in breakthrough drug project for the treatment of nerve pain | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-06-03 | Karolinska Development AB (publ) | Karolinska Development investerar i banbrytande läkemedelsprojekt för behandling av nervsmärta | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-19 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition ansöker om start av klinisk fas 2-studie med golexanolon | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-19 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Umecrine Cognition submits a Clinical Trial Application to initiate a phase 2 clinical trial with golexanolone | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-17 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Aprea Therapeutics förvärvar Atrin Pharmaceuticals | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-17 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Aprea Therapeutics acquires Atrin Pharmaceuticals | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-12 | Karolinska Development AB (publ) | Karolinska Development’s Annual General Meeting 2022 | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-12 | Karolinska Development AB (publ) | Karolinska Developments årsstämma 2022 | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-02 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Biosergen prepares Phase 2 study in mucormycosis infected patients | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-05-02 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Biosergen förbereder klinisk fas 2-studie med BSG005 mot systemisk svampinfektion | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-29 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Promimics aktie börjar idag handlas på Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-29 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Promimic’s stock starts trading today | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-29 | Karolinska Development AB (publ) | Delårsrapport för januari – mars 2022 | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-29 | Karolinska Development AB (publ) | Interim Report - January-March 2022 | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-25 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Promimic’s IPO offering fully subscribed | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-25 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Promimics noteringsemission fulltecknades | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-25 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign har rekryterat alla patienter till studien TOP FUSION | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-25 | Karolinska Development AB (publ) | Karolinska Development's portfolio company OssDsign completes patient enrolment to the TOP FUSION study | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-12 | Karolinska Development AB (publ) | Notice of Annual General Meeting in Karolinska Development AB (publ) | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-12 | Karolinska Development AB (publ) | Aktieägarna i Karolinska Development AB (publ) kallas till årsstämma | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-04 | Karolinska Development AB (publ) | Karolinska Development's portfolio company OssDsign enrolls the first patient to the multi-center registry PROPEL | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-04-04 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign inkluderar första patienten till multicenterregistret PROPEL | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-03-25 | Karolinska Development AB (publ) | Karolinska Developments årsredovisning för 2021 har publicerats | Rapporter | Visa Stäng |
|
|
||||
| 2022-03-25 | Karolinska Development AB (publ) | Karolinska Development Annual Report 2021 published | Rapporter | Visa Stäng |
|
|
||||
| 2022-03-23 | Karolinska Development AB (publ) | Karolinska Development's portfolio company OssDsign signs long-term contract with largest hospital network in France | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-03-23 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign tecknar avtal med framstående franskt sjukhusnätverk | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-28 | Karolinska Development AB (publ) | Ändring av antal aktier och röster i Karolinska Development | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-28 | Karolinska Development AB (publ) | Change of number of shares and votes in Karolinska Development | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-25 | Karolinska Development AB (publ) | Bokslutskommuniké för januari – december 2021 | Rapporter | Visa Stäng |
|
|
||||
| 2022-02-25 | Karolinska Development AB (publ) | Year-end Report - January-December 2021 | Rapporter | Visa Stäng |
|
|
||||
| 2022-02-21 | Karolinska Development AB (publ) | The rights issue is registered and the trading in Paid Subscription Shares ceases | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-21 | Karolinska Development AB (publ) | Emissionen registrerad och handeln med BTA upphör | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-07 | Karolinska Development AB (publ) | Karolinska Development AB announces definitive outcome in rights issue | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-07 | Karolinska Development AB (publ) | Karolinska Development AB offentliggör slutligt utfall i företrädesemission | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-04 | Karolinska Development AB (publ) | Karolinska Development AB announces preliminary outcome in rights issue | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-04 | Karolinska Development AB (publ) | Karolinska Development AB offentliggör preliminärt utfall i företrädesemission | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-03 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag AnaCardio tar in 33 MSEK för fortsatt klinisk utveckling av sin läkemedelskandidat mot hjärtsvikt | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-02-03 | Karolinska Development AB (publ) | Karolinska Development's portfolio company AnaCardio raises SEK 33 million to progress clinical development of a novel therapy for heart failure | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-26 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Karolinska Development på offensiven med emission | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-14 | Karolinska Development AB (publ) | Karolinska Development AB offentliggör prospekt och ej tidigare offentliggjord finansiell information med anledning av förestående företrädesemission samt bjuder in till investerarpresentationer | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-14 | Karolinska Development AB (publ) | Karolinska Development AB publishes prospectus including previously unpublished financial information due to upcoming rights issue, and invites to investor presentations | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-12 | Karolinska Development AB (publ) | Karolinska Developments extra bolagsstämma 2022 | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-12 | Karolinska Development AB (publ) | Karolinska Development’s Extraordinary General Meeting 2022 | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-11 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Umecrine Cognition presents preclinical data showing that golexanolone reduces neuroinflammation and counteracts motor symptoms | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-11 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition presenterar prekliniska data som visar att golexanolon minskar inflammation i hjärnan och motverkar motoriska symtom | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-11 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Svenska Vaccinfabriken appoints Richard Bethell as new CEO | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-01-11 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Svenska Vaccinfabriken utser Richard Bethell till ny vd | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-13 | Karolinska Development AB (publ) | Försäljningen av Karolinska Developments portföljbolag Forendo Pharma till Organon har framgångsrikt slutförts | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-13 | Karolinska Development AB (publ) | Organon’s acquisition of Karolinska Development's portfolio company Forendo Pharma has been successfully completed | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-10 | Karolinska Development AB (publ) | Notice of Extraordinary General Meeting in Karolinska Development AB (publ) | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-10 | Karolinska Development AB (publ) | Aktieägarna i Karolinska Development AB (publ) kallas till extra bolagsstämma | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-10 | Karolinska Development AB (publ) | Karolinska Development AB (publ) föreslår en företrädesemission om cirka 491 MSEK och offentliggör förslag till ny styrelseledamot | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-10 | Karolinska Development AB (publ) | Karolinska Development AB (publ) proposes a rights issue of approximately SEK 491 million, and publishes a proposal for a new Board member | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-01 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Modus Therapeutics initiates Phase 1b trial of its drug candidate sevuparin | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-12-01 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Modus Therapeutics inleder fas 1b-studie av läkemedelskandidaten sevuparin | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-22 | Finansinspektionen | Finansinspektionen: Flaggningsmeddelande i Karolinska Development AB | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-18 | Karolinska Development AB (publ) | Interim Report - January-September 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-18 | Karolinska Development AB (publ) | Delårsrapport för januari – september 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-15 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Organon förvärvar KD-bolaget Forendo Pharma | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-11 | Karolinska Development AB (publ) | Organon förvärvar Karolinska Developments portföljbolag Forendo Pharma till en total köpeskilling om 945 miljoner USD förutsatt att samtliga milstolpar uppnås | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-11 | Karolinska Development AB (publ) | Organon acquires Karolinska Development’s portfolio company Forendo Pharma at a total purchase price of USD 945 million provided fulfilment of all milestones | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-10 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Umecrine Cognition visar data inom ny indikation | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-09 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company receives approval to initiate a clinical Phase 1b trial with sevuparin in the Netherlands | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-09 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Modus Therapeutics erhåller godkännande om start av klinisk fas 1b-studie med sevuparin i Nederländerna | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-03 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Umecrine Cognition presents new data supporting the development of golexanolone as a treatment of primary biliary cholangitis | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-11-03 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition presenterar nya forskningsfynd som stöder utvecklingen av golexanolon för behandling av primär biliär kolangit | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-27 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Dilafor recruits first patient to Phase 2a study of tafoxiparin in women diagnosed with preeclampsia | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-27 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Dilafor meddelar att första patienten rekryterats till en fas 2a-studie av tafoxiparin i kvinnor med havandeskapsförgiftning | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-25 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag AnaCardio stärker organisationen inför klinisk studie av läkemedelskandidaten AC01 i patienter med hjärtsvikt | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-25 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company AnaCardio strengthens its organization to facilitate clinical trial of the drug candidate AC01 in heart failure | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-19 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Umecrine Cognition to collaborate with University College London to increase insights about golexanolone | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-19 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition ingår samarbete med University College London för att öka kunskapen om golexanolon | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-14 | Finansinspektionen | Finansinspektionen: Korrigering flaggningsmeddelande i Karolinska Development AB | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-06 | Finansinspektionen | Finansinspektionen: Flaggningsmeddelande i Karolinska Development AB | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-04 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign erhåller utökat marknadsgodkännande av amerikanska läkemedelsverket för OssDsign Cranial PSI | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-10-04 | Karolinska Development AB (publ) | Karolinska Development's portfolio company OssDsign receives expanded FDA market clearance for OssDsign Cranial PSI | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-09-09 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign inkluderar första patienten i en klinisk studie av det syntetiska bengraftet OssDsign Catalyst | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-09-09 | Karolinska Development AB (publ) | Karolinska Development's portfolio company OssDsign includes first patient to a clinical trial of the synthetic bone graft OssDsign Catalyst | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-08-24 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: KDs halvårsrapport ger en positiv bild | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-08-19 | Karolinska Development AB (publ) | Interim Report - January-June 2021 | Rapporter | Visa Stäng |
|
|
||||
| 2021-08-19 | Karolinska Development AB (publ) | Delårsrapport för januari – juni 2021 | Rapporter | Visa Stäng |
|
|
||||
| 2021-08-16 | Karolinska Development AB (publ) | Karolinska Development's portfolio company OssDsign launches the synthetic bone graft OssDsign Catalyst on the U.S. market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-08-16 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign lanserar bengraftsubstitutet OssDsign Catalyst i USA | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-08-12 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Aprea Therapeutics announces that FDA has issued a clinical hold on lymphoid malignancy program | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-08-12 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Aprea Therapeutics meddelar att FDA beslutat om uppehåll i bolagets kliniska studieprogram | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-22 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Aprea Therapeutics rapporterar positiva fas 2-resultat för eprenetapopt | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-22 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Aprea Therapeutics announces positive Phase 2 results for eprenetapopt | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-15 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Modus Therapeutics raises SEK 33 million through an oversubscribed issue and now prepares for listing | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-15 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Modus Therapeutics tillförs SEK 33 miljoner efter en övertecknad emission och förbereder nu inför börsnotering | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-14 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Umecrine Cognition raises capital through a successful share issue | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-14 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition genomför framgångsrik kapitalanskaffning | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-07 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Promimic receives market clearance for HAnano Surface in orthopedic oncology in collaboration with Onkos Surgical | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-07 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Promimic erhåller marknadsgodkännande för HAnano Surface inom onkologisk kirurgi i samarbete med Onkos Surgical | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-07 | Karolinska Development AB (publ) | Karolinska Development sells its holding in Lipidor AB and receives a net of SEK 4 million | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-07-07 | Karolinska Development AB (publ) | Karolinska Development avyttrar innehav i portföljbolaget Lipidor AB och erhåller netto 4 miljoner SEK | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-24 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Karolinska Developments vd kommenterar senaste tidens nyhetsflöde | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-17 | Karolinska Development AB (publ) | Karolinska Development expands its portfolio through new investment in AnaCardio | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-17 | Karolinska Development AB (publ) | Karolinska Development expanderar sin portfölj genom nyinvestering i AnaCardio | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-17 | Karolinska Development AB (publ) | Karolinska Development increases book value of Dilafor that is indirectly owned via KDev Investments AB by SEK 450 million | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-17 | Karolinska Development AB (publ) | Karolinska Development ökar det bokförda värdet av innehavet i portföljbolaget Dilafor som ägs indirekt via KDev Investments AB med SEK 450 miljoner | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-17 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Aprea Therapeutics uppnår primärt utfallsmått i kombinationsterapi av AML med eprenetapopt | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-17 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Aprea Therapeutics lead candidate drug eprenetapopt reaches primary efficacy endpoint in combination therapy of acute myeloid leukemia | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-15 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Modus Therapeutics och Imperial College London planerar klinisk studie av sevuparin mot svår malaria | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-15 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Modus Therapeutics and Imperial College London to conduct clinical study of sevuparin in severe malaria | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-11 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Promimic undersöker förutsättningarna för en listning på Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-11 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Promimic evaluates the possibility of a listing on Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-10 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Biosergen raises SEK 50 million through a successful unit offering and prepares for IPO | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-10 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Biosergen tillförs SEK 50 miljoner genom en fulltecknad företrädesemission och förbereder notering | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-01 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Dilafor presenterar positiva resultat från fas 2b-studie av tafoxiparin | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-06-01 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Dilafor presents positive results from a phase 2b study of tafoxiparin | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-21 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition förbereder notering på Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-21 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Umecrine Cognition initiates preparations for listing on Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-12 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company OssDsign raises SEK 270 million through an oversubscribed rights issue | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-12 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign tillförs SEK 270 miljoner genom en övertecknad företrädesemission med utnyttjat övertilldelningsoptionsprogram | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-05 | Karolinska Development AB (publ) | Karolinska Development’s Annual General Meeting 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-05 | Karolinska Development AB (publ) | Karolinska Developments årsstämma 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-05-04 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Karolinska Development mot nya milstolpar med förnyat team | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-29 | Karolinska Development AB (publ) | Interim Report - January-March 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-29 | Karolinska Development AB (publ) | Delårsrapport för januari – Mars 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-26 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: KD-bolaget Umecrine publicerar resultat i ansedd tidskrift | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-22 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Umecrine Cognition publicerar kliniska forskningsresultat i högt ansedd tidskrift | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-22 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Umecrine Cognition publishes clinical research results in a highly regarded journal | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-09 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Aprea Therapeutics erhåller särläkemedelsstatus i USA för eprenetapopt vid behandling av AML | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-09 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Aprea Therapeutics receives orphan drug designation for eprenetapopt in AML | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-06 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Dilafor har slutfört inklusionen till fas 2b-studie av läkemedelskandidaten tafoxiparin | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-04-06 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Dilafor completes patient inclusion to Phase 2b trial of its drug candidate tafoxiparin | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-30 | Karolinska Development AB (publ) | Aktieägarna i Karolinska Development AB (publ) kallas till årsstämma | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-30 | Karolinska Development AB (publ) | Notice of Annual General Meeting in Karolinska Development AB (publ) | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-25 | Karolinska Development AB (publ) | Karolinska Developments årsredovisning för 2020 har publicerats | Rapporter | Visa Stäng |
|
|
||||
| 2021-03-25 | Karolinska Development AB (publ) | Karolinska Development Annual Report 2020 published | Rapporter | Visa Stäng |
|
|
||||
| 2021-03-15 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Modus Therapeutics initiates preparations for listing on Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-15 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Modus Therapeutics förbereder notering på Nasdaq First North Growth Market | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-11 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Karolinska Developments Modus Therapeutics utvecklar sevuparin mot sepsis | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-10 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Modus Therapeutics förbereder kliniskt utvecklingsprogram för sevuparin vid sepsis / septisk chock | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-10 | Karolinska Development AB (publ) | Karolinska Development's portfolio company Modus Therapeutics prepares clinical development program of sevuparin in sepsis/septic shock | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-05 | Finansinspektionen | Finansinspektionen: Flaggningsmeddelande i Karolinska Development AB | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-05 | Finansinspektionen | Finansinspektionen: Flaggningsmeddelande i Karolinska Development AB | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-04 | Finansinspektionen | Finansinspektionen: Flaggningsmeddelande i Karolinska Development AB | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-04 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Karolinska Developments Forendo Pharma går vidare till fas II | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-03 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: KD-bolaget OssDsign satsar med ny strategi och emission | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-03 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag Forendo Pharma tar FOR-6219 vidare till fas 2-studie baserat på positiva fas 1-resultat | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-03 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company Forendo Pharma advances FOR-6219 to Phase 2 based on positive Phase 1 data | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-02 | Karolinska Development AB (publ) | Karolinska Development’s portfolio company OssDsign announces a fully guaranteed rights issue and launches new corporate strategy | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-02 | Karolinska Development AB (publ) | Karolinska Developments portföljbolag OssDsign genomför en fullt garanterad företrädesemission och lanserar ny bolagsstrategi | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-01 | Karolinska Development AB (publ) | Karolinska Development appoints Per Aniansson as CFO and Investment Director | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-03-01 | Karolinska Development AB (publ) | Karolinska Development utser Per Aniansson till ny finansdirektör och Investment Director | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-02-26 | Karolinska Development AB (publ) | Karolinska Development appoints Johan Dighed as Deputy CEO | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-02-26 | Karolinska Development AB (publ) | Karolinska Development utser Johan Dighed till vice vd | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-02-19 | Karolinska Development AB (publ) | Karolinska Development’s Extraordinary General Meeting 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-02-19 | Karolinska Development AB (publ) | Karolinska Developments extra bolagsstämma 2021 | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-02-16 | Karolinska Development AB (publ) | Karolinska Development AB (publ): BioStock: Milstolpar i sikte för Karolinska Development | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-02-11 | Karolinska Development AB (publ) | Bokslutskommuniké för januari – December 2020 | Rapporter | Visa Stäng |
|
|
||||
| 2021-02-11 | Karolinska Development AB (publ) | Year-end Report - January-December 2020 | Rapporter | Visa Stäng |
|
|
||||
| 2021-01-26 | Karolinska Development AB (publ) | Notice of Extraordinary General Meeting in Karolinska Development AB (publ) | Pressreleaser | Visa Stäng |
|
|
||||
| 2021-01-26 | Karolinska Development AB (publ) | Aktieägarna i Karolinska Development AB (publ) kallas till extra bolagsstämma | Pressreleaser | Visa Stäng |
|
|
||||
Kommande händelser